Genome‐scale modeling of human metabolism – a systems biology approach

Altered metabolism is linked to the appearance of various human diseases and a better understanding of disease‐associated metabolic changes may lead to the identification of novel prognostic biomarkers and the development of new therapies. Genome‐scale metabolic models (GEMs) have been employed for studying human metabolism in a systematic manner, as well as for understanding complex human diseases. In the past decade, such metabolic models – one of the fundamental aspects of systems biology – have started contributing to the understanding of the mechanistic relationship between genotype and phenotype. In this review, we focus on the construction of the Human Metabolic Reaction database, the generation of healthy cell type‐ and cancer‐specific GEMs using different procedures, and the potential applications of these developments in the study of human metabolism and in the identification of metabolic changes associated with various disorders. We further examine how in silico genome‐scale reconstructions can be employed to simulate metabolic flux distributions and how high‐throughput omics data can be analyzed in a context‐dependent fashion. Insights yielded from this mechanistic modeling approach can be used for identifying new therapeutic agents and drug targets as well as for the discovery of novel biomarkers. Finally, recent advancements in genome‐scale modeling and the future challenge of developing a model of whole‐body metabolism are presented. The emergent contribution of GEMs to personalized and translational medicine is also discussed.

[1]  A. Mardinoğlu,et al.  Systems medicine and metabolic modelling , 2012, Journal of internal medicine.

[2]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[3]  F. Hu,et al.  Contemporary Reviews in Cardiovascular Medicine Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk , 2010 .

[4]  Jason A. Papin,et al.  Functional integration of a metabolic network model and expression data without arbitrary thresholding , 2011, Bioinform..

[5]  Jeffrey D Orth,et al.  What is flux balance analysis? , 2010, Nature Biotechnology.

[6]  Malcolm Rowland,et al.  Physiologically-based pharmacokinetics in drug development and regulatory science. , 2011, Annual review of pharmacology and toxicology.

[7]  Karsten Zengler,et al.  The challenges of integrating multi-omic data sets. , 2010, Nature chemical biology.

[8]  Ralph Snyderman,et al.  Personalized health care: From theory to practice , 2012, Biotechnology journal.

[9]  E. Ruppin,et al.  Predicting Drug Targets and Biomarkers of Cancer via Genome-Scale Metabolic Modeling , 2012, Clinical Cancer Research.

[10]  L. Hood,et al.  Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine , 2012, Journal of internal medicine.

[11]  A. Barabasi,et al.  Blueprint for antimicrobial hit discovery targeting metabolic networks , 2010, Proceedings of the National Academy of Sciences.

[12]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[13]  P. Karp,et al.  Computational prediction of human metabolic pathways from the complete human genome , 2004, Genome Biology.

[14]  Jens Nielsen,et al.  Systems biology of lipid metabolism: From yeast to human , 2009, FEBS letters.

[15]  S. Bulik,et al.  Enzymatic features of the glucose metabolism in tumor cells , 2011, The FEBS journal.

[16]  I. Nookaew,et al.  Integration of clinical data with a genome-scale metabolic model of the human adipocyte , 2013, Molecular systems biology.

[17]  Aarash Bordbar,et al.  A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology , 2011, BMC Systems Biology.

[18]  Philip E. Bourne,et al.  Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model , 2010, PLoS Comput. Biol..

[19]  Markus J. Herrgård,et al.  Network-based prediction of human tissue-specific metabolism , 2008, Nature Biotechnology.

[20]  T. Ideker,et al.  Differential network biology , 2012, Molecular systems biology.

[21]  Adam M. Feist,et al.  The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli , 2008, Nature Biotechnology.

[22]  Christian L. Barrett,et al.  Systems biology as a foundation for genome-scale synthetic biology. , 2006, Current opinion in biotechnology.

[23]  U. Sauer,et al.  Article number: 62 REVIEW Metabolic networks in motion: 13 C-based flux analysis , 2022 .

[24]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Masaru Tomita,et al.  Systems Biology, Metabolomics, and Cancer Metabolism , 2012, Science.

[26]  Gregory Stephanopoulos,et al.  Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. , 2009, Journal of biotechnology.

[27]  E. Ruppin,et al.  Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism , 2010, Molecular systems biology.

[28]  Bernhard O. Palsson,et al.  Context-Specific Metabolic Networks Are Consistent with Experiments , 2008, PLoS Comput. Biol..

[29]  Marcel J. T. Reinders,et al.  Predicting Metabolic Fluxes Using Gene Expression Differences As Constraints , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[30]  Christian Baumgartner,et al.  Bioinformatic-driven search for metabolic biomarkers in disease , 2011, Journal of Clinical Bioinformatics.

[31]  Vinay Satish Kumar,et al.  Optimization based automated curation of metabolic reconstructions , 2007, BMC Bioinformatics.

[32]  María Martín,et al.  Ongoing and future developments at the Universal Protein Resource , 2010, Nucleic Acids Res..

[33]  Adil Mardinoglu,et al.  Inclusion of Interactions in Mathematical Modelling of Implant Assisted Magnetic Drug Targeting , 2012 .

[34]  Thomas S Deisboeck,et al.  Personalizing medicine: a systems biology perspective , 2009, Molecular systems biology.

[35]  C. Thompson,et al.  Therapeutic targets in cancer cell metabolism and autophagy , 2012, Nature Biotechnology.

[36]  F. Milagro,et al.  Individuality and epigenetics in obesity , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[37]  H Derendorf,et al.  Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling. , 1997, International journal of clinical pharmacology and therapeutics.

[38]  Adriele Prina-Mello,et al.  Theoretical modelling of physiologically stretched vessel in magnetisable stent assisted magnetic drug targetingapplication , 2011 .

[39]  D. Kell.  Systems biology, metabolic modelling and metabolomics in drug discovery and development. , 2006, Drug discovery today.

[40]  J. Palmer,et al.  Biomarkers and immune-modulating therapies for type 2 diabetes. , 2012, Trends in immunology.

[41]  C. Gille,et al.  HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology , 2010, Molecular systems biology.

[42]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[43]  Jens Nielsen,et al.  Sampling the Solution Space in Genome-Scale Metabolic Networks Reveals Transcriptional Regulation in Key Enzymes , 2010, PLoS Comput. Biol..

[44]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[45]  B. Palsson,et al.  Constraining the metabolic genotype–phenotype relationship using a phylogeny of in silico methods , 2012, Nature Reviews Microbiology.

[46]  H. Kitano.  Systems Biology: A Brief Overview , 2002, Science.

[47]  J. Nielsen,et al.  Translational and systems medicine , 2012, Journal of internal medicine.

[48]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[49]  Dan S. Tawfik.  Messy biology and the origins of evolutionary innovations. , 2010, Nature chemical biology.

[50]  Jie Zhang,et al.  Optimization of 13C isotopic tracers for metabolic flux analysis in mammalian cells. , 2012, Metabolic engineering.

[51]  R. Deberardinis,et al.  Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.

[52]  M. Jamei,et al.  PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. , 2010, Toxicology.

[53]  B. Palsson,et al.  A protocol for generating a high-quality genome-scale metabolic reconstruction , 2010 .

[54]  J. Nielsen,et al.  Integration of gene expression data into genome-scale metabolic models. , 2004, Metabolic engineering.

[55]  Ernesto S. Nakayasu,et al.  Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation , 2012, Molecular systems biology.

[56]  B. Palsson.  Metabolic systems biology , 2009, FEBS letters.

[57]  J. Nielsen,et al.  It Is All about MetabolicFluxes , 2003, Journal of bacteriology.

[58]  Intawat Nookaew,et al.  Prospects for systems biology and modeling of the gut microbiome. , 2011, Trends in biotechnology.

[59]  B. Palsson,et al.  Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions , 2010, Molecular systems biology.

[60]  B. Palsson,et al.  Large-scale in silico modeling of metabolic interactions between cell types in the human brain , 2010, Nature Biotechnology.

[61]  Natapol Pornputtapong,et al.  Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT , 2012, PLoS Comput. Biol..

[62]  U. Sauer,et al.  Systematic evaluation of objective functions for predicting intracellular fluxes in Escherichia coli , 2007, Molecular systems biology.

[63]  Solomon H. Snyder,et al.  Biliverdin reductase: A major physiologic cytoprotectant , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[64]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[65]  Fredrik H. Karlsson,et al.  Symptomatic atherosclerosis is associated with an altered gut metagenome , 2012, Nature Communications.

[66]  Jaeyun Sung,et al.  Molecular signatures from omics data: From chaos to consensus , 2012, Biotechnology journal.

[67]  Matej Oresic,et al.  Integrated Systems and Technologies Metabolic Associations of Reduced Proliferation and Oxidative Stress in Advanced Breast Cancer , 2012 .

[68]  Hermann-Georg Holzhütter,et al.  CardioNet: A human metabolic network suited for the study of cardiomyocyte metabolism , 2012, BMC Systems Biology.

[69]  Igor Goryanin,et al.  Compartmentalization of the Edinburgh Human Metabolic Network , 2010, BMC Bioinformatics.

[70]  Gabriela Kalna,et al.  Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.

[71]  Takashi Ishikawa,et al.  Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection , 2011, PloS one.

[72]  Steffen Borchers,et al.  Integrating Cellular Metabolism into a Multiscale Whole-Body Model , 2012, PLoS Comput. Biol..

[73]  Mitchell A. Lazar,et al.  De-Meaning of Metabolism , 2012, Science.

[74]  Rudi Balling,et al.  Revolutionizing medicine in the 21st century through systems approaches. , 2012, Biotechnology journal.

[75]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[76]  B. Palsson,et al.  Genome-scale models of microbial cells: evaluating the consequences of constraints , 2004, Nature Reviews Microbiology.

[77]  Fredrik H. Karlsson,et al.  A Closer Look at Bacteroides: Phylogenetic Relationship and Genomic Implications of a Life in the Human Gut , 2011, Microbial Ecology.

[78]  E. Lundberg,et al.  Creation of an antibody‐based subcellular protein atlas , 2010, Proteomics.

[79]  B. Palsson,et al.  Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Eytan Ruppin,et al.  Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model , 2010, Bioinform..

[81]  O. Demin,et al.  The Edinburgh human metabolic network reconstruction and its functional analysis , 2007, Molecular systems biology.

[82]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[83]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[84]  E. Ruppin,et al.  Predicting metabolic biomarkers of human inborn errors of metabolism , 2009, Molecular systems biology.

[85]  V. Mootha,et al.  Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation , 2012, Science.

[86]  Edward A Dennis,et al.  Applications of mass spectrometry to lipids and membranes. , 2011, Annual review of biochemistry.

[87]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[88]  R. Beger,et al.  The Role of Metabolic Biomarkers in Drug Toxicity Studies , 2008, Toxicology mechanisms and methods.

[89]  J. Nielsen,et al.  Uncovering transcriptional regulation of metabolism by using metabolic network topology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Sarah Hummasti,et al.  Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes , 2010, Circulation research.

[91]  Michael Darsow,et al.  ChEBI: a database and ontology for chemical entities of biological interest , 2007, Nucleic Acids Res..

[92]  Jason A. Papin,et al.  Mechanistic systems modeling to guide drug discovery and development. , 2013, Drug discovery today.

[93]  Chittibabu Guda,et al.  LMPD: LIPID MAPS proteome database , 2005, Nucleic Acids Res..

[94]  Jason A. Papin,et al.  Integration of expression data in genome-scale metabolic network reconstructions , 2012, Front. Physio..